Solstein Capital’s West Pharmaceutical WST Stock Holding History

Solstein Capital’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.2K	Hold	34	–	–	﹤0.01%	321
2026 Q1	$8.52K	Hold	34	–	–	﹤0.01%	341
2025 Q4	$9.36K	Hold	34	–	–	﹤0.01%	338
2025 Q3	$8.92K	Hold	34	–	–	﹤0.01%	341
2025 Q2	$7.44K	Hold	34	–	–	﹤0.01%	361
2025 Q1	$7.61K	Hold	34	–	–	﹤0.01%	252
2024 Q4	$11.1K	Hold	34	–	–	0.01%	234
2024 Q3	$10.2K	Hold	34	–	–	0.01%	242
2024 Q2	$11.2K	Hold	34	–	–	0.01%	232
2024 Q1	$13.5K	Hold	34	–	–	0.01%	222
2023 Q4	$12K	Hold	34	–	–	0.01%	225
2023 Q3	$12.8K	Hold	34	–	–	0.01%	209
2023 Q2	$13K	Hold	34	–	–	0.01%	214
2023 Q1	$11.8K	Hold	34	–	–	0.01%	199
2022 Q4	$8K	Hold	34	–	–	0.01%	222
2022 Q3	$8K	Hold	34	–	–	0.01%	240
2022 Q2	$10K	Hold	34	–	–	0.01%	261
2022 Q1	$14K	Hold	34	–	–	0.01%	273
2021 Q4	$16K	Hold	34	–	–	0.01%	289
2021 Q3	$14K	Hold	34	–	–	0.01%	326
2021 Q2	$12K	Hold	34	–	–	0.01%	318
2021 Q1	$10K	Buy	+34	New	+$9.73K	0.01%	298
2020 Q2	–	Sell	-158	Closed	-$24K	–	305
2020 Q1	$24K	Hold	158	–	–	0.09%	129
2019 Q4	$24K	Buy	+158	New	+$23K	0.05%	170

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Solstein Capital's WST Position: Q2 2026 in Review

Solstein Capital held its West Pharmaceutical (WST) position steady in Q2 2026 at 34 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #321.

Solstein Capital first reported a position in WST in Q4 2019 and has held it in 24 quarters since. The position peaked at $24K in Q1 2020. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Solstein Capital held 34 shares of West Pharmaceutical worth $12.2K as of Q2 2026.
Solstein Capital left its West Pharmaceutical share count unchanged in Q2 2026.
West Pharmaceutical made up ﹤0.01% of Solstein Capital's portfolio in Q2 2026, its #321 holding.
Solstein Capital first reported a position in West Pharmaceutical in Q4 2019 and has held it in 24 quarters since.
Solstein Capital's West Pharmaceutical position peaked at $24K in Q1 2020.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Solstein Capital's 13F filing for Q2 2026, filed 13 Aug 2026.